ActualMeds
ActualMeds provides "medication reconciliation on demand"TM for high risk patients at the point of care
- Stage Full Product Ready
- Industry Healthcare Services
- Location East Hartford, CT, USA
- Currency USD
- Founded February 2009
- Employees 5
- Website actualmeds.com
Company Summary
ActualMeds is the first solution to provide “medication reconciliation on demand” at point of care, integrating it with on-going care management. Seamlessly combining medication information from the EHR, Rx claims databases, and a patient structured interview, ActualMeds produces the most accurate and current medication history. For Payers and Providers with high risk patients, operating efficiencies, quality metrics and outcomes are improved.
Team
-
CTO, Co-Founder
Anne Marie has prior experience in rapidly evolving HIT sector, as well as being a successful technology executive and career entrepreneur with over 18 years of experience including an early e-health company acquired by Web MD, and a consumer technology company Digiticians, which she co-founded. Previously, she was EVP Vice President/ Chief Informatics Systems Officer at IC Sciences. B.S. EE U of Dayton ; M.S. in EE Tufts U
-
CEO
Patricia brings 25 years of executive operating experience from both early stage and mature companies in the medical device, diagnostics, life science companies, including Life Technologies, T Cell Sciences and Sigma Aldrich Corporation. Prior to ActualMeds , Patricia founded RedTail Solutions, a profitable SaaS company serving small manufacturers in supply chain. MBA CWRU; AB Biology Kenyon College
-
Chief Clinical Officer
Joseph is a former Chief Executive Officer of ASCP Ventures, Inc., VP Clinical Products with Mirixa Corporation and has over 20 years experience in the long-term care setting. He is Board certified in Geriatric Pharmacy and is expert in geriatric pharmacotherapy, gero-psychiatric pharmaceutical care, quality indicators, health management and medication therapy management services. RPh St. Louis College of Pharmacy;
-
Chief Scientific Officer and Co-Founder
Patricia J. Neafsey, RD, PhD Pharmacologist, Professor Emeritus School of Nursing at the University of Connecticut, has authored over 100 peer reviewed publications and was the principal investigator on grants from private foundations , and the NIH that funded the development of a computer-based intervention to improve patient adherence to antihypertensive regimens . She holds an M.S. from Cornell University, doctorate from University of CT.
Advisors
-
Board AdvisorBob LearyDirector ActualMedsUnconfirmedMike Stocker, M.D.Director, ActualMedsUnconfirmed
-
Dave AndersonBoard AdvisorUnconfirmed
Previous Investors
-
Dave Anderson, Supply Chain VenturesUnconfirmedMichael Stocker, MD Chairman, Health And Hospital Corp NYCUnconfirmedNew York Digital Health AcceleratorUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.